ONEMEDNET CORPORATION Increase (Decrease) in Accounts Payable and Accrued Liabilities
ONEMEDNET CORPORATION (ONMD) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $160.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- ONEMEDNET CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$285.00K.
- ONEMEDNET CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $445.00K, a 43.55% increase year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $314.00K.
- ONEMEDNET CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $243.00K, a 14.13% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $717.00K, a 72.77% increase from fiscal 2022.
- ONEMEDNET CORPORATION increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $415.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$285.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $160.00K 10-Q · filed 2026-08-14 | $474.00K derived: sum of 3 quarters · filed 2026-08-14 | $717.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $445.00K S-1/A · filed 2026-07-08 | $759.00K derived: sum of 2 quarters · filed 2026-07-08 | $1.00M derived: sum of 3 quarters · filed 2026-07-08 | $501.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $314.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $557.00K derived: sum of 2 quarters · filed 2026-07-08 | $56.00K derived: sum of 3 quarters · filed 2026-08-14 | $366.00K S-1/A · filed 2026-07-08 | ||||
| 2025-09-30 | $243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$258.00K derived: sum of 2 quarters · filed 2026-08-14 | $52.00K 10-Q · filed 2025-11-14 | $25.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$501.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | -$191.00K 10-Q · filed 2026-08-14 | -$380.00K 10-Q · filed 2025-08-13 | -$218.00K derived: sum of 3 quarters · filed 2026-08-14 | $65.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $310.00K S-1/A · filed 2026-07-08 | $216.00K 10-Q · filed 2025-05-14 | $283.00K derived: sum of 2 quarters · filed 2026-07-08 | $566.00K derived: sum of 3 quarters · filed 2026-07-08 | $1.14M derived: sum of 4 quarters · filed 2026-07-08 | |||
| 2024-12-31 | -$27.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $256.00K derived: sum of 2 quarters · filed 2026-07-08 | $826.00K derived: sum of 3 quarters · filed 2026-07-08 | $1.21M S-1/A · filed 2026-07-08 | $1.49M 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $853.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.23M 10-Q · filed 2025-11-14 | $1.23M 10-Q · filed 2024-12-17 | $1.61M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $570.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $950.00K 10-Q · filed 2025-08-13 | $1.33M derived: sum of 3 quarters · filed 2025-08-13 | $1.39M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $380.00K 10-Q · filed 2025-05-14 | $757.00K derived: sum of 2 quarters · filed 2025-05-14 | $818.00K derived: sum of 3 quarters · filed 2025-05-14 | $826.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $438.00K derived: sum of 2 quarters · filed 2025-04-15 | $446.00K derived: sum of 3 quarters · filed 2025-04-15 | $717.00K 10-K · filed 2025-04-15 | $1.37M 10-K · filed 2024-04-09 | |||
| 2023-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $69.00K derived: sum of 2 quarters · filed 2024-12-17 | $340.00K 10-Q · filed 2024-12-17 | $340.52K 10-Q · filed 2023-11-20 | $475.00K derived: sum of 4 quarters · filed 2024-12-17 | |||
| 2023-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-11 | $279.00K 10-Q · filed 2024-12-11 | $414.00K derived: sum of 3 quarters · filed 2024-12-11 | |||||
| 2023-03-31 | $271.00K 10-Q · filed 2024-12-05 | $406.00K derived: sum of 2 quarters · filed 2024-12-05 | ||||||
| 2022-12-31 | $135.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $415.00K 10-K/A · filed 2024-11-05 | $1.93M 10-K · filed 2024-04-09 | |||||
| 2022-09-30 | $280.00K 8-K/A · filed 2024-11-22 | $240.82K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |